Effect of background insulin therapy on cardiovascular outcomes with SGLT-2 inhibitors in type 2 diabetes: A Meta-analysis of Cardiovascular Outcome Trials

Cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in Asians with type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials

Diabetes & Metabolic Syndrome Clinical Research & Reviews ◽

10.1016/j.dsx.2020.04.051 ◽

2020 ◽

Vol 14 (4) ◽

pp. 715-722

Author(s):

Awadhesh Kumar Singh ◽

Ritu Singh

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Cardiovascular Outcome ◽

Faculty Opinions recommendation of SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734434782.793555944 ◽

2019 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Secondary Prevention ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Renal Outcomes

Generalizability of sodium-glucose co-transporter-2 inhibitors cardiovascular outcome trials to the type 2 diabetes population: a systematic review and meta-analysis

Cardiovascular Diabetology ◽

10.1186/s12933-020-01067-8 ◽

2020 ◽

Vol 19 (1) ◽

Cited By ~ 5

Author(s):

Marco Castellana ◽

Filippo Procino ◽

Rodolfo Sardone ◽

Pierpaolo Trimboli ◽

Gianluigi Giannelli

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Comparison of New Glucose-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes: A Network Meta-Analysis of Cardiovascular Outcome Trials

SSRN Electronic Journal ◽

10.2139/ssrn.3436269 ◽

2019 ◽

Author(s):

Caroline K. Kramer ◽

Chang Ye ◽

Ravi Retnakaran

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Secondary Prevention ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Glucose Lowering ◽

Prevention Of Cardiovascular Disease

Update on Cardiovascular Safety of Incretin-Based Therapy in Adults With Type 2 Diabetes Mellitus: A Meta-Analysis of Cardiovascular Outcome Trials

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.04.003 ◽

2019 ◽

Vol 43 (7) ◽

pp. 538-545.e2 ◽

Cited By ~ 4

Author(s):

Osamah M. Alfayez ◽

Abdulaali R. Almutairi ◽

Ali Aldosari ◽

Majed S. Al Yami

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Cardiovascular Safety ◽

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

The Lancet ◽

10.1016/s0140-6736(18)32590-x ◽

2019 ◽

Vol 393 (10166) ◽

pp. 31-39 ◽

Cited By ~ 749

Author(s):

Thomas A Zelniker ◽

Stephen D Wiviott ◽

Itamar Raz ◽

Kyungah Im ◽

Erica L Goodrich ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Secondary Prevention ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Renal Outcomes

CARDIOVASCULAR BENEFIT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN FEMALE PATIENTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF RECENT CARDIOVASCULAR OUTCOME TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(19)30847-2 ◽

2019 ◽

Vol 73 (9) ◽

pp. 239

Author(s):

David Aguilar ◽

Efstratios Koutroumpakis ◽

Heinrich Taegtmeyer

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Cardiovascular Benefit

Comparative safety of glucagon like peptide‑1 receptor agonists in patients with type 2 diabetes: a network meta-analysis of cardiovascular outcome trials

10.37766/inplasy2020.8.0122 ◽

2020 ◽

Author(s):

Chuanjun Zhuo ◽

Hongjun Tian ◽

Lina Wang ◽

Xiangyang Gao ◽

Li Ding ◽

...

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Comparative Safety

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes

Diabetes Care ◽

10.2337/dc20-2080 ◽

2020 ◽

pp. dc202080

Author(s):

Francesco Zaccardi ◽

David E. Kloecker ◽

John B. Buse ◽

Chantal Mathieu ◽

Kamlesh Khunti ◽

...

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Effects ◽

Cardiovascular Outcome ◽

Glucose Lowering ◽

Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials

Endocrine ◽

10.1007/s12020-019-01931-y ◽

2019 ◽

Vol 65 (1) ◽

pp. 15-24 ◽

Cited By ~ 6

Author(s):

Dario Giugliano ◽

Maria Ida Maiorino ◽

Miriam Longo ◽

Giuseppe Bellastella ◽

Paolo Chiodini ◽

...

Keyword(s):

Heart Failure ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcome ◽